Oracle Health Sciences releases its new mHealth Connector Cloud Service that will enable clinical study teams to remotely collect e-Source data from patient sensors, wearables and apps during their clinical trials, all while delivering a new level of patient engagement and centricity.
“We are thrilled to announce our new mHealth Connector as it holds great promise in speeding clinical trials and bringing more drugs to market faster. Being able to take what used to be patient-recorded data and outcomes via paper forms and site visits can now be done via mHealth sensors and wearables that have the potential to shorten trial times and reduce costs, while allowing sick patients to remain in the comfort or their homes versus traveling to and from trial sites. To improve patient enrollment in clinical trials, study teams must put the patient at the center of everything they do, and emerging technologies such as wearables and sensors hold the key,” stated Oracle Health Services General Manager Steve Rosenberg.
Oracle mHealth Connect Cloud Service Overview
Oracle’s mHealth Connector Cloud Service allows for easy connection to existing clinical systems with a wide variety of e-Sources, enabling therapeutic teams to obtain more accurate and rich patient data, improve adherence to study protocols, better understand the safety and efficacy of trial drugs and improve patient centricity with remote patient monitoring.
This solution also supports a number of integration approaches and Oracle Health Sciences is currently exploring integration efforts with a wide ecosystem of mobile health companies such as Validic, MC10 and CMT’s CleverCap medication adherence solutions, and solutions developer, POSSIBLE Mobile.
“At CMT, our CleverCap product family blends the best technology with the connected patient to help track and improve medication dosing habits in clinical trials. Our collaboration with Oracle Health Sciences enables a seamless real-time display of dosing patterns data into the eClinical systems that clinical trial sites and clinical teams utilize, alongside other essential clinical trial data,” said CMT CEO Moses Zonana in a statement.
Being able to integrate existing EMR and new onboarding technologies together without interruption ensures that patients will not experience a lag in care and caretakers will not lose pertinent information necessary for proper documentation and new drug recommendations.
“[By] using the Oracle mHealth Connector Cloud Service, we were able to easily transfer patient data from our Apple ResearchKit apps to the clinical trial cloud application. The integration process was straightforward and painless,” stated POSSIBLE Mobile Chief Technology Officer Jay Graves.
In addition to new integrations, this capability will create entirely new and improved ways of working for life sciences companies. Oracle Health Sciences is collaborating with Accenture to design processes to make the most of these possibilities.
